Heparin cofactor II: a new marker for pre-eclampsia

被引：15

作者：

Bellart, J

Gilabert, R

Cabero, L

Fontcuberta, J

Monasterio, J

Miralles, RM

机构：

[1] Univ Rovira & Virgili, Hosp Univ Joan XXIII, Serv Ginecol & Obstet, Unitat Med Maternofetal, Tarragona, Spain

[2] Univ Rovira & Virgili, Dept Ciencies Med Basiques, E-43201 Reus, Spain

[3] Univ Autonoma Barcelona, Hosp Maternoinfantil Vall Hebron, Serv Obstet & Ginecol, E-08193 Barcelona, Spain

[4] Univ Autonoma Barcelona, Hosp Santa Cruz & San Pablo, Hematol Serv, E-08193 Barcelona, Spain

[5] Univ Autonoma Barcelona, Hosp Gen Valle Hebron, E-08193 Barcelona, Spain

来源：

BLOOD COAGULATION & FIBRINOLYSIS | 1998年 / 9卷 / 02期

关键词：

heparin cofactor II; pre-eclampsia; hypertension; pregnancy;

D O I：

10.1097/00001721-199803000-00014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The plasma levels of heparin cofactor II were determined in pregnant women who were either normotensive, or had essential hypertension, gestational hypertension or pre-eclampsia during the third trimester and 72 h after delivery. Heparin cofactor II levels in the pre-eclampsia group were depressed. The clinical relevance of this finding is the potential utility of heparin cofactor II plasma levels in the differential diagnostic between non-proteinuric hypertension and pre-eclampsia. (C) 1998 Lippincott-Raven Publishers.

引用

页码：205 / 208

页数：4

共 10 条

[1] AN ANTICOAGULANT DERMATAN SULFATE PROTEOGLYCAN CIRCULATES IN THE PREGNANT WOMAN AND HER FETUS [J].

ANDREW, M ;

MITCHELL, L ;

BERRY, L ;

PAES, B ;

DELORME, M ;

OFOSU, F ;

BURROWS, R ;

KHAMBALIA, B .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :321-326

[2] Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation [J].

Bellart, J ;

Gilabert, R ;

Fontcuberta, J ;

Carreras, E ;

Miralles, RM ;

Cabero, L .

AMERICAN JOURNAL OF PERINATOLOGY, 1998, 15 (02) :81-85

[3] Fibrinolysis changes in normal pregnancy [J].

Bellart, J ;

Gilabert, R ;

Fontcuberta, J ;

Borrell, M ;

Miralles, RM ;

Cabero, L .

JOURNAL OF PERINATAL MEDICINE, 1997, 25 (04) :368-372

[4]

Bellart J, 1997, MED SCI RES, V25, P699

[5]

BELLART J, 1997, IN PRESS HYPERT PREG

[6]

CARON C, 1991, THROMB HAEMOSTASIS, V66, P410

[7]

LIU L, 1998, THROMB HAEMOSTASIS, V73, P405

[8]

MASSOUCH M, 1989, J LAB CLIN MED, V114, P679

[9] THE RELATIONSHIP BETWEEN CLINICAL SIGNS AND HYPERCOAGULABLE STATE IN TOXEMIA OF PREGNANCY [J].

TERAO, T ;

MAKI, M ;

IKENOUE, T ;

GOTOH, K ;

MURATA, M ;

IWASAKI, H ;

SHIBATA, J ;

NAKABAYASHI, M ;

MURAOKA, M ;

TAKEDA, Y ;

SAKAMOTO, S ;

KOBAYASHI, T ;

IMAI, N ;

ODA, H ;

SAMESHIMA, H .

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1991, 31 (02) :74-85

[10]

TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713

← 1 →